VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AMSF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AMSFAMERISAFE, Inc.
$33.75$634M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAMSFQuarterly Financials

AMERISAFE, Inc. (AMSF) Quarterly Financials

120+ quarters historyFree accessUpdated daily

AMERISAFE, Inc. (AMSF) quarterly income statement — complete revenue, gross profit & net income history

AMSF Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Revenue80.09M81.59M81.98M81.1M72.61M74.05M78.71M75.85M80.51M80.12M72.66M75.67M
Revenue Growth %10.3%10.19%4.16%6.93%-9.8%-7.58%8.33%0.23%2.61%0.43%1.76%11.21%
Medical Costs & Claims46.44M28.95M47.88M46.89M46.21M37.5M44.79M46.54M45.87M0041.49M
Medical Cost Ratio %57.98%35.48%58.4%57.82%63.64%50.64%56.91%61.36%56.98%0%0%54.83%
Gross Profit33.65M52.6M34.11M34.21M26.4M36.55M33.92M29.3M34.63M80.12M72.66M34.19M
Gross Margin %42.02%64.47%41.6%42.18%36.36%49.36%43.09%38.64%43.02%100%100%45.17%
Gross Profit Growth %27.47%43.94%0.55%16.72%-23.77%-54.39%-53.32%-14.28%2.94%111.67%157.15%53.5%
Operating Expenses23.49M39.91M16.63M16.75M15.18M19.77M16.13M15.56M13.89M56.17M60.33M14.62M
OpEx / Revenue %29.33%48.91%20.28%20.65%20.9%26.7%20.49%20.52%17.25%70.11%83.03%19.32%
Depreciation & Amortization0150K183K195K214K258K277K230K328K355K0349K
Combined Ratio %87.31%84.4%78.68%78.48%84.55%77.35%77.39%81.88%74.23%70.11%83.03%74.14%
Operating Income10.16M12.69M17.48M17.45M11.22M16.77M17.79M13.74M20.75M23.95M12.33M19.57M
Operating Margin %12.69%15.56%21.32%21.52%15.45%22.65%22.61%18.12%25.77%29.89%16.97%25.86%
Operating Income Growth %-9.46%-24.32%-1.75%27%-45.91%-29.95%44.34%-29.76%-3.67%-6.64%-8.36%174.72%
EBITDA10.16M12.84M17.66M17.65M11.44M17.03M18.07M13.97M21.07M24.3M12.33M19.92M
EBITDA Margin %12.69%15.74%21.55%21.76%15.75%23%22.96%18.42%26.18%30.33%16.97%26.32%
Interest Expense000000000000
Non-Operating Income000000000000
Pretax Income10.16M12.69M17.48M17.45M11.22M16.77M17.79M13.74M20.75M23.95M12.33M19.57M
Pretax Margin %12.69%15.56%21.32%21.52%15.45%22.65%22.61%18.12%25.77%29.89%16.97%25.86%
Income Tax2.02M2.27M3.66M3.5M2.27M3.58M3.47M2.75M3.82M4.77M2.37M3.94M
Effective Tax Rate %19.83%17.89%20.95%20.05%20.25%21.34%19.5%20.02%18.41%19.9%19.19%20.14%
Net Income8.14M10.42M13.82M13.96M8.95M13.19M14.32M10.99M16.93M19.18M9.96M15.63M
Net Margin %10.17%12.77%16.85%17.21%12.32%17.82%18.2%14.49%21.02%23.94%13.71%20.65%
Net Income Growth %-8.98%-21%-3.53%26.94%-47.13%-31.21%43.8%-29.65%-2.39%-7.69%-12.32%154.84%
EPS (Diluted)0.430.550.720.730.470.690.750.570.881.000.520.81
EPS Growth %-8.51%-20.29%-4%28.07%-46.59%-31%44.23%-29.63%-2.22%-7.41%-11.86%153.13%
EPS (Basic)0.430.550.730.730.470.690.750.580.891.000.520.82
Diluted Shares Outstanding18.86M18.97M19.07M19.12M19.15M19.12M19.11M19.15M19.21M19.22M19.22M19.2M